Conference Coverage
Conference Coverage
Global burden of brain disorders surpasses cardiovascular disease and cancer
“The burden of brain conditions will increase as populations continue to grow and age.”
Conference Coverage
New ESH hypertension guidelines aim for simplified message
A new feature of the guidelines is the upgrading of beta-blockers in the treatment algorithms.
Latest News
Residency match process under scrutiny again, this time by AMA
AMA may study alternatives to the current residency matching program in an effort to improve residents’ compensation and other job-related issues...
Conference Coverage
OASIS and PIONEER PLUS support high-dose oral semaglutide
OASIS-1 showed that “oral semaglutide 50 mg may represent an effective option for the treatment of obesity, particularly in patients who prefer...
Conference Coverage
‘Striking’ benefit of lipid lowering in primary prevention
“If patients can’t tolerate a statin, then treat them with bempedoic acid. The bottom line is that these patients just need to be treated.”
Conference Coverage
SURMOUNT-2: Tirzepatide rings up major weight loss in type 2 diabetes
Taken together, results from SURMOUNT-1 and SURMOUNT-2 appear to make a good case for a weight-loss indication that will not depend on whether a...
Conference Coverage
Upping CO2 does not benefit OHCA patients: TAME
“These out-of-hospital cardiac arrest patients are a very diverse group, and it may be possible that some patients could have benefited from...
Conference Coverage
BMI ‘vastly underestimates’ true obesity
“We’re at the start of the end of BMI.”
Conference Coverage
Big trial reassures on heart safety of testosterone in men
“The community of physicians who prescribe testosterone to men was waiting with bated breath” for the TRAVERSE results.
Conference Coverage
Ticagrelor may reduce brain lesions after carotid stenting
There were also significantly fewer cases of a composite of adverse clinical events with ticagrelor versus clopidogrel, but no difference in rates...
Conference Coverage
Immediate statin after acute stroke reduces disability
It was “safe, with no increased risk of bleeding, hepatotoxicity, or muscle toxicity.”